跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,738 条关于
“IL-31 receptor alpha”
全部
19,738
临床试验
8,780
药物
3,018
机构
158
资讯
7,782
去年
Galderma's Nemolizumab (Nemluvio) Receives FDA Approval for Moderate-to-Severe Atopic Dermatitis
9个月前
Galderma Initiates Phase II Trial of Nemolizumab for Chronic Pruritus of Unknown Origin
去年
Nemluvio Shows Sustained Long-Term Efficacy in Atopic Dermatitis with Two-Year Extension Data
去年
Galderma Launches Phase II Trials of Nemolizumab for Systemic Sclerosis and Chronic Pruritus of Unknown Origin
去年
Galderma's Phase III OLYMPIA 1 Trial Results Show Nemolizumab Significantly Improves Prurigo Nodularis Symptoms
3个月前
Zai Lab's Zoci Demonstrates 62.5% Intracranial ORR in Small Cell Lung Cancer, Global BLA Submission Planned for Late 2027
8个月前
Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03
4个月前
Elanco Launches Befrena, New Anti-IL-31 Monoclonal Antibody for Canine Allergic Dermatitis
去年
Attovia Therapeutics Initiates Phase 1 Trial of Novel Anti-IL-31 Therapy for Chronic Pruritus
2年前
FDA Approves Galderma's Nemluvio as First IL-31 Inhibitor for Prurigo Nodularis
第 1 页,共 779 页
上一页
下一页